Estrogen suppression of 8-week treatment with exemestane combined with triptorelin versus triptorelin alone in healthy premenopausal women
| Autor: | E. Di Salle, N. Pirotta, Peter Buchan, Giorgio Massimini, Riccardo Spinelli, Maria Gabriella Jannuzzo |
|---|---|
| Rok vydání: | 2004 |
| Předmět: |
endocrine system
Cancer Research medicine.medical_specialty medicine.drug_class business.industry Triptorelin female genital diseases and pregnancy complications chemistry.chemical_compound Endocrinology Oncology Exemestane chemistry Estrogen Internal medicine medicine business hormones hormone substitutes and hormone antagonists Hormone medicine.drug |
| Zdroj: | Journal of Clinical Oncology. 22:2041-2041 |
| ISSN: | 1527-7755 0732-183X |
| DOI: | 10.1200/jco.2004.22.90140.2041 |
| Popis: | 2041 Background: Gonadotrophin-releasing hormone agonists (Gn-RHa), such as triptorelin (T), reduce the ovarian estrogen production in premenopausal women, thus inducing a reversible postmenopausal... |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|